The GeCIP Board is tasked with overseeing and steering GeCIP. It is comprised of:
- representatives from funders (National Institute for Health Research, Wellcome Trust, Medical Research Council, Cancer Research UK);
- a representative from the Genomics England Scientific Advisory Committee;
- patient representative(s);
- a representative from each of the devolved nations
- and a representative from each of the Cancer, Rare Diseases, and Cross-Cutting arms of GeCIP, as decided by the GeCIP Steering Committee.
Membership
Its current membership is as follows
Member name | Position |
---|---|
Kay Davies | Chair |
Mark Caulfield | Genomics England, Chief Scientist and Deputy Chair |
Sue Hill | NHS England, Chief Scientific Officer |
Mark Bale | DH/NIHR |
Michael Parker | Ethic Advisory Committee Representative |
Michael Dunn | Wellcome Trust |
Nathan Richardson | Medical Research Council |
Maria A Cerone | Cancer Research UK |
Tom Barlow | Devolved Nations Representative for Scotland |
Jon Bisson | Devolved Nations Representative for Wales |
Ian Young | Devolved Nations Representative for Northern Ireland |
Colin Cooper | Cross-Cutting GeCIP Domain Representative |
Chrissie Thirlwell | Cancer GeCIP Domain Representative |
Henry Houlden | Rare diseases GeCIP Domain Representative |
Leanne Leriche | Participant Panel Representative |
Alison Fox | Participant Panel Representative |
Dave McCormick | Participant Panel Representative |
Documentation
GeCIP Board Terms of Reference